Provider attitudes towards quality improvement for myocardial infarction care in northern Tanzania.

Autor:	Coaxum LA; Department of Emergency Medicine, Duke University Medical Center, Durham, North Carolina, United States of America., Sakita FM; Department of Emergency Medicine, Kilimanjaro Christian Medical Centre, Moshi, Tanzania., Mlangi JJ; Department of Emergency Medicine, Kilimanjaro Christian Medical Centre, Moshi, Tanzania., Kweka GL; Department of Emergency Medicine, Kilimanjaro Christian Medical Centre, Moshi, Tanzania., Tarimo TG; Department of Emergency Medicine, Kilimanjaro Christian Medical Centre, Moshi, Tanzania., Temu GA; Department of Internal Medicine, Kilimanjaro Christian Medical Centre, Moshi, Tanzania., Kilonzo KG; Department of Internal Medicine, Kilimanjaro Christian Medical Centre, Moshi, Tanzania., Arthur D; Duke Global Health Institute, Duke University Medical Center, Durham, North Carolina, United States of America., Bettger JP; Department of Health and Rehabilitation Sciences, Temple University, Temple University, Philadelphia, Pennsylvania, United States of America., Thielman NM; Duke Global Health Institute, Duke University Medical Center, Durham, North Carolina, United States of America., Limkakeng AT; Department of Emergency Medicine, Duke University Medical Center, Durham, North Carolina, United States of America., Hertz JT; Department of Emergency Medicine, Duke University Medical Center, Durham, North Carolina, United States of America.; Duke Global Health Institute, Duke University Medical Center, Durham, North Carolina, United States of America.
Jazyk:	angličtina
Zdroj:	PLOS global public health [PLOS Glob Public Health] 2024 Apr 04; Vol. 4 (4), pp. e0003051. Date of Electronic Publication: 2024 Apr 04 (Print Publication: 2024).
DOI:	10.1371/journal.pgph.0003051
Abstrakt:	Introduction: Myocardial Infarction (MI) is a leading cause of death worldwide. In high income countries, quality improvement strategies have played an important role in increasing uptake of evidence-based MI care and improving MI outcomes. The incidence of MI in sub-Saharan Africa is rising, but uptake of evidence-based care in northern Tanzania is low. There are currently no published quality improvement interventions from the region. The objective of this study was to determine provider attitudes towards a planned quality improvement intervention for MI care in northern Tanzania. Methods: This study was conducted at a zonal referral hospital in northern Tanzania. A 41-question survey, informed by the Theoretical Framework for Acceptability, was developed by an interdisciplinary team from Tanzania and the United States. The survey, which explored provider attitudes towards MI care improvement, was administered to key provider stakeholders (physicians, nurses, and hospital administrators) using convenience sampling. Results: A total of 140 providers were enrolled, including 82 (58.6%) nurses, 56 (40.0%) physicians, and 2 (1.4%) hospital administrators. Most participants worked in the Emergency Department or inpatient medical ward. Providers were interested in participating in a quality improvement project to improve MI care at their facility, with 139 (99.3%) strongly agreeing or agreeing with this statement. All participants agreed or strongly agreed that improvements were needed to MI care pathways at their facility. Though their facility has an MI care protocol, only 88 (62.9%) providers were aware of it. When asked which intervention would be the single-most effective strategy to improve MI care, the two most common responses were provider training (n = 66, 47.1%) and patient education (n = 41, 29.3%). Conclusion: Providers in northern Tanzania reported strongly positive attitudes towards quality improvement interventions for MI care. Locally-tailored interventions to improve MI should include provider training and patient education strategies. Competing Interests: ATL’s institution received grant funding from Roche Diagnostics, Abbott Laboratories, Jiaxing Wisetest Biotech, Co., Quidel, Brainbox, Forest, Becton, SENSE, and Ophirex for studies in which he was a co-investigator. ATL also served on the advisory board for SenJam Pharma. JTH’s institution received funding from Roche Diagnostics for a study in which he was a co-investigator. (Copyright: © 2024 Coaxum et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu